Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02236000
Title A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors NSABP Foundation Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Cleveland Clinic Weston Weston Florida 33331 United States Details
Cancer Care Specialists of Central Illinois Decatur Illinois 62526 United States Details
Crossroads Cancer Center Effingham Illinois 62401 United States Details
Cancer Care Specialists of Central Illinois-Swansea Swansea Illinois 62226 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Stephenson Cancer Center at the University of Oklahoma Health Services Center Oklahoma City Oklahoma 73104 United States Details
UPMC- Hillman Cancer Center-Monroeville Monroeville Pennsylvania 15146 United States Details
Alleheny General Hospital Pittsburgh Pennsylvania 15212 United States Details
Hillman Cancer Center Pittsburgh Pennsylvania 15213 United States Details
Magee Womens Hospital of UPMC Pittsburgh Pennsylvania 15213 United States Details
University of Pittsburgh Pittsburgh Pennsylvania 15213 United States Details
UPMC- St. Margaret Pittsburgh Pennsylvania 15215 United States Details
UPMC Hillman Cancer Center North Hills at Passavant Pittsburgh Pennsylvania 15237 United States Details
Women & Infants Hospital of Rhode Island Providence Rhode Island 02905 United States Details
West Virginia University Morgantown West Virginia 26501 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field